Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.55 USD | -0.63% |
|
+8.77% | -0.28% |
Jun. 18 | Stifel Initiates Celldex Therapeutics at Buy Rating With $58 Price Target | MT |
Jun. 11 | Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing | MT |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Press Releases